About Science Team News

Oviva Therapeutics, Inc. is a Cambrian BioPharma, Inc PipeCo

© 2023 Oviva Therapeutics, Inc. All rights reserved.

Privacy Policy Press

Back to News and Publications

See media contact

Oviva collects $12M, inks licensing deal with Mass General to develop therapeutics for ovarian health

5 mins to read

May 24, 2022

We want to hear from you.

Oviva Therapeutics, Inc. is a Cambrian BioPharma, Inc PipeCo
© 2022 Oviva Therapeutics, Inc. All rights reserved.

Privacy Policy Press

>